Pola Peresepan Antidiabetik Pasien Diabetes Melitus Tipe 2 Rawat Jalan di PKU Muhammadiyah Yogyakarta

Main Article Content

Qarriy ‘Aina Urfiyya
Aisyah

Abstract

Background. Diabetes mellitus (DM) is a chronic metabolic disease that continues to increase in number followed by the risk of irrational drug use. This study aims to determine the pattern of antidiabetic prescribing in outpatient type 2 DM patients at PKU Muhammadiyah Yogyakarta. Research Methods: This study used an observational design with retrospective data collection in the medical records of outpatients with type 2 diabetes mellitus for the period October 2021 - March 2022. The sampling technique used a saturated sample of 155 medical records. Data analysis was carried out on antidiabetic therapy based on type and class. The results: Antidiabetic prescriptions include oral antidiabetic monotherapy (22.6%), insulin monotherapy (24.5%), a combination of 2 antidiabetics (31%), a combination of 3 or more oral antidiabetics (3.2%), an antidiabetic-insulin combination (16.1%) and an insulin-insulin combination (2.6%). Conclusion: The most common antidiabetic prescription was insulin monotherapy with a percentage of 31%. The most widely used insulin is novorapid insulin with a percentage of 20%.

Downloads

Download data is not yet available.

Article Details

How to Cite
‘Aina Urfiyya, Q., & Aisyah. (2023). Pola Peresepan Antidiabetik Pasien Diabetes Melitus Tipe 2 Rawat Jalan di PKU Muhammadiyah Yogyakarta. AFAMEDIS, 4(2), 148-153. https://doi.org/10.61609/afamedis.v4i2.94
Section
Articles

References

ADA (American Diabetes Association). American Diabetes Association Standards of Medical Care In Diabetes-2019. Diabetes Journal; 2019;42(1)
AL-Musawe, L., Martis A.P., Raposo, J.F dan Torre, C., The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis’, Diabetes Research and Clinical Practice; 2019; (155)107804. doi: 10.1016/j.diabres.2019.107804.
Al-Wahibi, M., Balkhi, B., Alhawwasi, T.M., Alkofide, H., Alduhaim, N., Aladulali, R., Drweesh, H., dan Sambamoorthi, U., Open Access Research Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open; 2018. doi:10.1136/bmjopen-2017-020852
Ashar M, Hanif A, Jadoon A, et al. Assessment of Drug Use Pattern Using WHO Prescribing Indicators in the Medication Therapy of Indoor Diabetic Patients. International Journal of Basic Medical Sciences and Pharmacy, 2016; 6(1): 2049-4963.
Brunton dan Marta. Type 2 Diabetes: The Role Of Insulin. the Journal Of Family Practice;2014. 54(5):445-52
Dutta S, Anjoom M, Beg M, Varma A, Bawa S. Study of prescribing pattern in diabetes mellitus patients in a tertiary care teaching hospital at Dehradun, Uttarakhand. International Journal of Medical Science and Public Health, 2014; 3(11): 1351-4.doi: 10.5455/ijmsph.2014.130820141
Drug Information Handbook (DIH). 2014. LEXICOMP
Haile F, Bule M, Gelaw B, Tegegne G, Defersha A. Anti-diabetic medication pattern in Adama Hospital Medical College East Shoa Zone, Oromia, Ethiopia. International Journal of Pharma Science, 2015; 5(4): 1200-8
Hans N. A prospective study on prescribing pattern in type 2 diabetes mellitus outpatients in a tertiary care institution. Int J Med Sci Diagn Res. 2020, 4:44-47
Inayah, I., Hamidy, M. Y., & Yuki, R. P. R. Pola Penggunaan Insulin Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Di Rumah Sakit X Pekanbaru Tahun 2014. Jurnal Ilmu Kedokteran; 2017. 10(1), 38-43. Doi:10.26891/Jik.V10i1.2016.38-43
International Diabetes Federation (IDF). IDF Diabetes Atlas 8 ed, International Diabetes Federation. https://diabetesatlas.org/. 2017. diakses 27 Juli 2022
Kementrian Kesehatan Republik Indonesia (Kemenkes RI). Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehatan RI; 2018. 53(9):1689–1699.
Papanas Dan Maltezos, Metformin: A Review Of Its Use In The Treatment Of Type 2 Diabetes. Review. Clinical Medicine: Therapeutics;2009.
Perkumpulan Endokrinologi Indonesia (PERKENI). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. PB PERKENI. 2021
Purwakanthi, A., Nyimas, N.A.S., Huntari, H., Erny, K., Gambaran Penggunaan Obat Diabetes Mellitus Pada Pasien Diabetes Mellitus Tipe 2. Jambi Medical Journal. 2020. 8(1): 40-46
Prashant, D., Dan Sanjay, K., 2019. Treatment Patterns In Type 2 Diabetes Mellitus: A Cross‑Sectional Study. Indian Journal Of Health Sciences And Biomedical Research Kleu
Ramdini, D.A., Lilik, K.W., Dwi, A., Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe 2 Pada Pasien Rawat Jalan Di Puskesmas Pasir Sakti Tahun 2019. Jurnal Farmasi Lampung; 2020
Rahmawati., 2020. Treatment Pattern And Precision Evaluation Of Diabetes Mellitus Therapy Complications Of Chronic Renal Failure At RSUD Undata Palu, Farmasains. Jurnal Ilmu Farmasi Dan Kesehatan, 5(2), 71-76.P-Issn : 2086-3373 | E-Issn : 2620-987x
Wulandari, Y., Evaluasi Rasionalitas Penggunaan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan. Skripsi. 2021. Prodi Farmasi:Univ Jendral Achmad Yani Yogyakarta